Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004960 |
YEM_ID: | YEM-395 |
XU_ID: | XU-47 |
ID: | TCMBANKHE004960/YEM-395/XU-47 |
植物拉丁名: |
|
功能与主治: | To transform stasis and disperse concretion, anticancer./carcinoma. |
药用植物名: | 云南美登木|美登木 |
药名: | 云南美登木 |
来源: | 云南民族药物志：第二卷|云南省丽江市宁蒗彝族自治县阿海水电站附近 |
药用部位: | leaf|叶和茎 |
使用民族: | 傣族/基诺族 |
KUMST_ID1: | KUMST-BS-0051 |
KUMST_ID2: | KMUST-20180731044 |
TCM_ID_id: | 1750 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000942 | 4-[β-d-apiofuranosyl-(1→6)-β-d-glucopyra-nosyloxy]-3-methoxypropiophenone | C21H30O12 | CCC(=O)C1=CC(=C(C=C1)OC2C(C(C(C(O2)COC3C(C(CO3)(CO)O)O)O)O)O)OC | ||
| TCMBANKIN001551 | isaridinA | C39H53N5O7 | 703.9 g/mol | CC(C)CC1C(=O)N2CCCC2C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)O1)CC3=CC=CC=C3)C)C(C)C)C)CC4=CC=CC=C4 | |
| TCMBANKIN001829 | maytanprine | C35H48ClN3O10 | 706.2 g/mol | CCC(=O)N(C)C(C)C(=O)OC1CC(=O)N(C2=C(C(=CC(=C2)CC(=CC=CC(C3(CC(C(C4C1(O4)C)C)OC(=O)N3)O)OC)C)OC)Cl)C | |
| TCMBANKIN004543 | ergosta- 7, 22-diolefin- 3β,5 α,6β,9α-tetrol | ||||
| TCMBANKIN007414 | maytansine | C34H46ClN3O10 | 692.2 g/mol | CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)C(C)N(C)C(=O)C)C)C)OC)(NC(=O)O2)O | |
| TCMBANKIN007538 | Ansam acrolid | C15H21N6O4S+ | C[S+](CCC(C(=O)O)N)CC1=CC(C(O1)N2C=NC3=C2N=CN=C3N)O | ||
| TCMBANKIN008787 | ergosta- 7, 22-diolefin- 3β,5α,6 β-triol | ||||
| TCMBANKIN012694 | chaetoglobosin B | C32H36N2O5 | 528.6 g/mol | CC1CC=CC2C(C(=C(C3C2(C(=O)C=CC(=O)C(C(=C1)C)O)C(=O)NC3CC4=CNC5=CC=CC=C54)C)C)O | |
| TCMBANKIN012733 | maytanbutine | C36H50ClN3O10 | 720.2 g/mol | CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)C(C)N(C)C(=O)C(C)C)C)C)OC)(NC(=O)O2)O | |
| TCMBANKIN014452 | chaetoglobosin A | C32H36N2O5 | 528.6 g/mol | CC1CC=CC2C3C(O3)(C(C4C2(C(=O)C=CC(=O)C(C(=C1)C)O)C(=O)NC4CC5=CNC6=CC=CC=C65)C)C | |
| TCMBANKIN017125 | 3- phenyl- 1,2- propanediol(17)和1- hydroxyl- 3- phenyl acetone | ||||
| TCMBANKIN018939 | isariinB | C30H53N5O7 | 595.8 g/mol | CCCCCCC1CC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O1)C(C)C)C)CC(C)C)C(C)C | |
| TCMBANKIN019339 | angucycline | C29H27NO11 | CC(=O)OCC1C(C(CC(O1)C2=C(C3=C(C=C2)C(=O)C4=C5C(=NC=C4C3=O)CCCC5=O)O)OC(=O)C)OC(=O)C | ||
| TCMBANKIN020673 | sitoindoside Ⅰ | ||||
| TCMBANKIN022455 | 2α-hydroxylursolic acid | ||||
| TCMBANKIN023178 | ergosta- 6,22-diolefin- 5α(25),8α-epidioxy- 3-formate | ||||
| TCMBANKIN025400 | 1- isobutyroxymethyi cyclohex- 1(6)- ene- 3,4,5- tetrol- isobutyrate | ||||
| TCMBANKIN032833 | 2α-hydroxy oleanic acid | ||||
| TCMBANKIN033711 | 6,11-dimenthyl-2,6,10-dodecatrien-1-ol | 456.88 | |||
| TCMBANKIN034695 | 2,3- diacetoxyl maytenusone | C13H16FN3O6 | CC1C(C(C(O1)N2C=C(C(=NC2=O)N)F)OC(=O)C)OC(=O)C | ||
| TCMBANKIN036278 | ergosta- 6, 22-diolefin- 5α,8 α-epidioxy- 3- pl | ||||
| TCMBANKIN041889 | 4-Deacetyl-11(15-1)-abeo-baccatinVI | C35H44O13 | C1(=C(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])C2([H])[H])[C@]2(C(C([H])([H])[H])(O[H])C([H])([H])[H])[C@@]([H])(OC(=O)c3c([H])c([H])c([H])c([H])c3[H])[C@]4([H])[C@@](C([H])([H])[H])([C@@]([H])( OC(=O)C([H])([H])[H])C([H])([H])[C@@]([H])(OC5([H])[H])[C@]45O[H])[C@]([H])(OC(=O)C([H])([H])[H])[C@]1([H])OC(=O)C([H])([H])[H] | ||
| TCMBANKIN045404 | salaspermic acid | salaspermicacid | C30H48O4 | 473 | C1([H])([H])C([H])([H])[C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]([H])(C([H])([H])[C@@](C(O[H])=O)(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C([H])([H])[H])C([H ])([H])C3([H])[H])[C@]34C([H])([H])[H])[C@]4([H])C([H])([H])C5([H])[H])[C@@]5(C([H])([H])O6)[C@@]([H])(C([H])([H])[H])[C@]16O[H] |
| TCMBANKIN057937 | galactitol | meso-galactitol;18089-21-9; EINECS 210-165-2; CHEBI:16813; D0256_SIGMA; NSC 1944; ZINC04521466; (2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexol; 40742-76-5; ZINC02034453; AI3-19423;C01507; C-25615; Sorbo; I0725; I14-60913; KB-53227; CTK8B4049; L-Iditol, >=98%; FBPFZTCFMRRESA-UNTFVMJOSA-N; AC1NUSPZ; DB-051581; 488-45-9; ANW-43765; CHEBI:18202; MolPort-003-848-134; L-Iditol; CC-29952; AKOS024258141; FT-0627851; K-9194; KS-00000XZK; WURCS=1.0/1,0/[h2121h]; SCHEMBL435775; ZINC5178945; W-202860; (2S,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol; L-Idit; MFCD00064289;dulcitol | C6H14O6 | 182.17 g/mol | C(C(C(C(C(CO)O)O)O)O)O |
| TCMBANKIN058837 | Supraene | trans-Squalene; SQUALENE; 94016-35-0; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-; (E,E,E,E)-Squalene; InChI=1/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24; 442785_SUPELCO; Squalene, Spinacene, Supraene; AIDS-017396; 2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene; 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; All-trans-Squalene; 111-02-4; EINECS 203-826-1; (14E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-,; S3626_SIGMA; 7683-64-9; CHEBI:15440; 2,6,10,14,18,22-tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (6E,10E,14E,18E)-; 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene; AIDS017396; Spinacene; C00751; NSC93748; (all-E)-2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene; LMPR01060008; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (all-E)-; CCRIS 711; (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene;squalene | C30H50 | 410.72 | CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(C)C)C)C)C |
| TCMBANKIN059147 | ergosterin | ergosterol;24-Methylcholesta-5,7,22-trien-3beta-ol; 24alpha-Methyl-22E-dehydrocholestero; (3beta,22E)-Ergosta-5,7,22-trien-3-ol; (7S,9AR,11AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,6H,7H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; 45480_FLUKA; (24R)-Ergosta-5,7,22-trien-3b-ol; MEGxm0_000450; Ergosterin; 24R-Methylcholesta-5,7,22E-trien-3b-ol; 57-87-4; Ergosterol; ergosta-5,7,22E-trien-3beta-ol; (3beta)-Ergosta-5,7,22-trien-3-ol; C01694; 5,7,22-Ergostatrien-3beta-ol; AIDS064232; E6510_SIGMA; Provitamin D2; (22E)-Ergosta-5,7,22-trien-3.beta.-ol; A831651; ergosta-5,7,22-trienol; ergosta-5,7,22-trien-3 beta-ol; 24R-Methylcholesta-5,7,22E-trien-3beta-ol; ACon0_000429; ERG; ST073383; (3S,10R,13R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 24-Methylcholesta-5,7,22-trien-3b-ol; ACon1_000637; (3beta,2E)-Ergosta-5,7,22-trien-3-ol; Provitamine D2; AIDS-064232; 24a-Methyl-22E-dehydrocholesterol; ergosta-5,7,22-trien-3-ol; 47130U_SUPELCO; LMST01030093; (22E)-ergosta-5,7,22-trien-3beta-ol; ZINC04084618; (3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 3beta-Hydroxy-5,7,22-ergostatriene; CHEBI:16933; (3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (22E,24S)-24-methylcholesta-5,7,22-trien-3beta-ol | C28H44O | 396.6 g/mol | CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN059162 | 11,12- dihydroxy- 8,11,13- abietrien- 7-one | torreyayunnin | C20H26O4 | 330.4 g/mol | CC(C)C1=C(C(=C2C(=C1)C(=O)CC3C2(CCC(=O)C3(C)C)C)O)O |
| TCMBANKIN060139 | maytenonic acid | C30H48O3 | 456.7 g/mol | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab